T protein-1. Chem Immunol 1999, 72:7?9. 8. Li MQ, Li HP, Meng YH, Wang XQ, Zhu XY, Mei J, Li DJ: Chemokine CCL2 enhances survival and invasiveness of endometrial stromal cells in an autocrine manner by activating Akt and MAPK/Erk1/2 signal pathway. Fertil Steril 2012, 97(four):919?29. 9. Loberg RD, Day LL, Harwood J, Ying C, St John LN, Giles R, Neeley CK, Pienta KJ: CCL2 is usually a potent regulator of prostate cancer cell migration and proliferation. Neoplasia 2006, 8:578?86.Astrocytes have been grown in main culture as described previously [62]. Briefly, the cerebral hemispheres of newborn SJL and G1H+/- mice had been removed, the meninges had been very carefully removed off, and the cerebral tissues have been dissociated with trypsin. The dissociated cells were seeded at 1.4 ?104 viable cells/cm2 inside a plastic culture flask and grown for 2 weeks in Dulbecco’s modified Eagle’s medium with 20 F-12 and 10 fetal bovine serum at 37 in a 5 CO2 incubator. Ahead of experiments, immunocytochemistry confirmed that over 95 of your cells have been stained positively for the astrocytic marker GFAP.2410440-12-7 Data Sheet For proliferation assay, cells have been plated on 96-well plates (4 ?103 cells/well) andKawaguchi-Niida et al. Acta Neuropathologica Communications 2013, 1:21 http://actaneurocomms.org/content/1/1/Page 11 of10. Lu Y, Cai Z, Galson DL, Xiao G, Liu Y, George DE, Melhem MF, Yao Z, Zhang J: Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine issue for prostate cancer growth and invasion. Prostate 2006, 66:1311?318. 11. El Khoury J, Luster AD: Mechanisms of microglia accumulation in Alzheimer’s disease: therapeutic implications. Trends Pharmacol Sci 2008, 29:626?32. 12. Huang DR, Wang J, Kivisakk P, Rollins BJ, Ransohoff RM: Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J Exp Med 2001, 193:713?26. 13. Hughes PM, Allegrini PR, Rudin M, Perry VH, Mir AK, Wiessner C: Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model. J Cereb Blood Flow Metab 2002, 22:308?17. 14. Baron P, Bussini S, Cardin V, Corbo M, Conti G, Galimberti D, Scarpini E, Bresolin N, Wharton S, Shaw PJ, Silani V: Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis. Muscle Nerve 2005, 32:541?44. 15. Gupta PK, Prabhakar S, Sharma S, Anand A: A predictive model for amyotrophic lateral sclerosis (ALS) diagnosis. J Neurol Sci 2012, 312:68?2. 16. Henkel JS, Engelhardt JI, Sikl L, Simpson EP, Kim SH, Pan T, Goodman JC, Siddique T, Beers DR, Appel SH: Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue.Formula of 1350518-27-2 Ann Neurol 2004, 55:221?35.PMID:33641563 17. Simpson EP, Henry YK, Henkel JS, Smith RG, Appel SH: Improved lipid peroxidation in sera of ALS individuals: a possible biomarker of illness burden. Neurology 2004, 62:1758?765. 18. Wilms H, Sievers J, Dengler R, Bufler J, Deuschl G, Lucius R: Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: additional proof for microglial activation in neurodegeneration. J Neuroimmunol 2003, 144:139?42. 19. Beers DR, Zhao W, Liao B, Kano O, Wang J, Huang A, Appel SH, Henkel JS: Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice. Brain Behav Immun 2011, 25:1025?035. 20. Henkel JS, Beers DR, Sikl L, Appel SH: The chemokine MC.